Purchase Order 75N91020P00979

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biologicals valued at $13,401.67 on March 12, 2020, with an ultimate completion date of April 9, 2020. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation on August 5, 2015, valued at $3,011.04 for scientific instruments, reagents, or consumables with a firm fixed price structure. Performance occurred in Baltimore, Maryland, with an ultimate completion date of September 28, 2016. No set-aside applied to this simplified acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to Eppendorf North America, Inc. for $12,841.60 on September 22, 2020, with completion on December 22, 2020. The order covers laboratory equipment on a firm fixed-price basis. Place of performance is Bethesda, Maryland.</p>

The National Cancer Institute awarded a $19,905 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 2, 2024, with an ultimate completion date of November 1, 2025. This contract is part of the FY26 UDO Initiative and was issued without set-aside designation, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instrumentation, reagents, and...

The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $24,095.00 on August 6, 2021, for EVOS M5000 DSS equipment with a one-year reorder exchange provision. The order was issued to administratively de-obligate unexpiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) prior to the September 30, 2021 close of the fiscal year period of availability. Performance occurs at Grand Island, New York. The purchase order carries firm...

<p>The National Cancer Institute awarded a purchase order to Thermo Electron North America LLC valued at $24,954.71 on February 5, 2020, with an ultimate completion date of August 10, 2020. Performance is at Bethesda, Maryland. The order is for service agreement work under firm fixed-price terms with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $3,516.74 on January 8, 2016, for firm fixed price commercial items with an ultimate completion date of October 31, 2016. Performance is located in Carlsbad, California. No set-aside was applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a firm fixed price purchase order to Life Technologies Corporation of Carlsbad, California. With a period of performance from September 2020 through December 2023, this $20 million contract supports NIH/NCI's mission to conduct and fund cancer research by providing life science research products and services. As a leading supplier of innovative tools for scientific discovery and biomedical...